Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: QUALEFFO
Total 1 results
Bugra Ince
Terminated
Validation of the Turkish Version of QUALEFFO-31
Osteoporosis
Turkey
Sponsors and Collaborators
ProteoSys AG
Celtaxsys Aus Pty Limited
Elim Pediatric Pharmaceuticals Inc.
San MediTech(Huzhou)Co.,Ltd.
Caritas Freetown
CRMBM-CEMEREM
AMTC & Associates
Rui-hua Xu, MD, PhD
Cardresearch
Victor Montori
Fondren Orthopedic Group L.L.P.
University Medical Center Goettingen
The Fifth Affiliated Hospital of Zunyi Medical College
Societa Italiana di Endoscopia Digestiva
Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
Norsk Proteinintolerance, Norway
Donders Institute for Brain, Cognition and Behavior
Alberta Children's Hospital, Calgary, Canada
Diego Hernan Giunta, MD
University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
View Full List
Medical Conditions
Postcomatose Unawareness State
Lymphedema of Arm
Malignant Ascites Due to Epithelial Carcinoma
Auditory Hallucination, Verbal
Spermatogenesis Arrest
Fibromyalgia Syndrome, Primary
Non-compressible Torso Hemorrhage
Normal Diameter of Optic Nerve
Tube Disorders Eustachian
Gynecologic Cancer
Orbital Tumor
Fever, Sweats, and Hot Flashes
Atrial Fibrillation, Postoperative
Stereotactic Radioablation for Ventricular Tachycardia
Disturbance of Activity and Attention
Non-dystrophic Myotonias
Prostate Cancer Recurrent
Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
Plasmodium Falciparum Malaria (Drug Resistant)
Tularaemia
View Full List
Drug Interventions
Ruxolitinib
Flibanserin 100 mg dose every evening
Epimedium Prenylflavonoids Extract
Atezolizumab
CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
Cytarabine ARA-C
Polyethylene glycol 3350
Lamivudine
Insulin
Cetrorelix 78 mg + 78 mg
PF-00868554
Mupirocin Calcium
Methotrexate
Oxycodone, fentanyl
Indoximod
SERETIDE Diskus
Topotecan
Bortezomib/dexamethasone
HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
Enzalutamide, Abiraterone
View Full List
CROs by country
Contract Research Organizations in Australia
Contract Research Organizations in Chile
Contract Research Organizations in Congo
Contract Research Organizations in Cyprus
Contract Research Organizations in Denmark
Contract Research Organizations in Jordan
Contract Research Organizations in Lebanon
Contract Research Organizations in Madagascar
Contract Research Organizations in Mongolia
Contract Research Organizations in Türkiye
Contract Research Organizations in Ukraine
Contract Research Organizations in Vietnam
Contract Research Organizations in Zimbabwe
CRO list by country
CROs in Pakistan
DRK Pharma Solutions
Cyntax Health Projects Pvt Ltd
IQVIA
Dow Institute of Biological Biochemical & Pharmaceutical Sciences (IBBPS)
Metrics Research
Orci Trials Ltd
MAC Clinical Research®
ACROSS Global
SGS
Dimension Research
All CROs in Pakistan
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe